MitoRx Therapeutics is a preclinical stage platform biotech developing a new category of innovative small molecule mitochondrial metabolic modulators for weight loss with muscle protection in obesity-related indications and metabolic disease.
Company Details
- Employees
- 16
- Founded
- 2021
- Address
- Oxford, Oxfordshire, Gb
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Keywords
- mitochondrial disease, neuromuscular disease, biotech, preclinical, drug discovery, mitochondria, MitoRx, muscular dystrophy, neurodegenerative disease, first-in-class, obesity, diabetes, muscle preservation, cardiometabolic, muscle protection, weight loss.
- HQ
- Oxford, Oxfordshire
Mitorx Therapeutics Questions
Mitorx Therapeutics's website is https://www.mitorxtherapeutics.com/
Mitorx Therapeutics's LinkedIn profile is https://uk.linkedin.com/company/mitorx-therapeutics
Mitorx Therapeutics has
16 employees.
View email and phone details for 16
employees at Mitorx Therapeutics.
Mitorx Therapeutics's industry is
Biotechnology Research
Mitorx Therapeutics's top competitors are
Clock.bio,
Samsara Therapeutics,
Bloomsbury Genetic Therapies,
Vacv Biotherapeutics,
Senisca,
Alevin Therapeutics Ltd,
Shift Bioscience,
Infinitopes,
Adaptimmune,
Greywolf Therapeutics.
Mitorx Therapeutics's categories are Biotechnology Research
Mitorx Therapeutics's founding year is 2021
